Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
TrumpRx Zepbound Price 2026: Full GLP-1 Cost List
articleA price-by-price walkthrough of what TrumpRx.gov lists for Zepbound, Mounjaro, Ozempic, and Wegovy as of August 17, 2026, plus the self-pay eligibility rules and a clear line between TrumpRx and the separate Medicare GLP-1 Bridge.
Zepbound Cost With Insurance in 2026: Coverage and Medicare
articleWith commercial coverage of the Zepbound single-dose pen and the savings card, eligible patients pay as little as $25 per fill, with savings capped at $1,300 per calendar year on that tier. Medicare beneficiaries have a new route from July 1, 2026: the CMS GLP-1 Bridge, which covers the Zepbound KwikPen only at $50 a month. This guide covers the insured path, prior authorization, and appeals.